Biorex Diagnostics was founded 20 years ago and has become a leading manufacturer of in vitro diagnostics.
We offer accurate, reliable products across multiple product ranges including; clinical chemistry, blood grouping, immunoassay ELISA and rapid testing. Using a global distributor network, Biorex products are available to hospitals, clinics, blood banks and research facilities in over 100 countries.
We are dedicated to developing market leading products and are committed to investing in the research and development of new products and collaborating with external research facilities and universities globally.
Regain Your Life.
Biorex Diagnostics have an extensive range of IVD products available across multiple categories including key example here, key example here & key example here.
Contact us for more information about our products & services
Become a Distributor
Over the past 20 years, Biorex has built a strong network of distributors that represent us in over 100 markets. We work with distributors to deliver accurate, reliable products, customer service and are happy to assist with marketing and additional requirements to maximise the potential of each distributor in their markets.
Interested in becoming a distributor? Complete a contact form and a member of our sales team will be in touch.
Make May Purple For Stroke
Make May Purple For Stroke Biorex Diagnostics are supporting Make May Purple for Stroke. Stroke is the result of a clot in a blood vessel leading to the brain, suddenly blocking or
Blood Grouping One of the most frequently performed clinical procedures to aid in improving tissue oxygen delivery in hospitalised patients in red blood cell (RBC) transfusion. Cross-matching is a mandatory test
The Importance of Diagnostic Testing
The Importance of Diagnostic Testing Healthcare starts with and depends on diagnostics, whether it’s cancer, diabetes, infectious diseases or serious health threats, diagnostics are at the front and centre. Diagnostics enable
Renal Testing Chronic kidney disease (CKD) has continued to burden the global population as illustrated through its increasing contribution to mortality and morbidity rates and the associated financial costs. In Europe,